Noteworthy news from medtech start-ups. This month we profile AugmentRx, which is developing bioceramic bulking agents for treating urinary incontinence, and RegenTec, a developer of an injectable bone filler.

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions Database, providing comprehensive transaction coverage from 1991 to the present.

Brief summaries of recent clinical developments in the device industry, including an early ovarian cancer test, urine-based cancer screening, technology for remote pathology analysis, a renal tubule assist device, and a new filter that protects blood recipients from Mad Cow disease.

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.